4 Medical Clinical Solutions — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

4 Medical Clinical Solutions is a private clinical research services company founded in 2019, operating dedicated trial sites in Manchester and London. It positions itself as a patient-centric SMO with cumulative team experience exceeding 130 years, focusing on efficient patient recruitment for pharmaceutical sponsors through access to a large potential patient population and a proprietary repository of pre-profiled patients. The company's business model is service-based, generating revenue by conducting trials for partners, and it appears to be in a revenue-generating stage given its operational sites and active patient recruitment campaigns.

MigraineDiabetesPsoriasis

Technology Platform

Operational platform centered on a proprietary patient database (35,000+ patients) and real-world evidence (RWE) capabilities for rapid clinical trial feasibility and patient recruitment. Utilizes dedicated, purpose-built research sites with standardized quality systems.

Opportunities

The growing global clinical trials market and persistent industry challenge of patient recruitment create strong demand for efficient Site Management Organisations (SMOs).

The increasing reliance on Real-World Evidence (RWE) for regulatory and market access decisions aligns with 4MCS's data capabilities.

The UK's established clinical research environment provides a stable base for operations.

Risk Factors

Revenue is entirely dependent on winning competitive contracts from pharmaceutical sponsors in a crowded market.

Operational and regulatory risks are concentrated in only two physical sites.

Failure to recruit patients on time for contracted trials would damage reputation and financial performance.

Competitive Landscape

4MCS competes in the fragmented clinical trial services market against large global Contract Research Organizations (CROs), other niche SMOs, and hospital-based academic research centers. Its differentiation is based on a patient-centric, dedicated site model and claimed rapid recruitment via a proprietary patient database.

More companies in Digital Health & Biotech SaaS →More companies in United Kingdom →